Top-line results of TIGER-2 Phase 3 clinical trial for CF treatment
Links shared publicly online about this topic.
- 608total visits
Top-line results of TIGER-2 Phase 3 clinical trial for CF treatment
View full resource at news-medical.net
Tags: Cystic Fibrosis, Pharma, Phase 3 Clinical Trial, Clinical Trial
Most Recently Shared on January 3, 2011 at 12:39 pm By:
Top-line results of TIGER-2 Phase 3 clinical trial for CF treatment: Inspire Pharmaceuticals, Inc. announced tod... http://bit.ly/eQv8IN
Allergan Announces Positive Top-Line Results from Phase III BOTOX® Overactive Bladder Program - Yahoo! News
news.yahoo.com — “From Yahoo! News: Allergan, Inc. (NYSE: AGN) today announced that two Phase III clinical trials of BOTOX® (onabotulinumtoxinA) as a potential treatment option for patients with idiopathic overactive bladder met their pre-specified primary endpoints. Results from both Phase III clinical trials demonstrate that BOTOX® significantly reduced urinary incontinence (bladder leakage) episodes compared to placebo for the treatment of overactive bladder patients with urinary incontinence who were not adeq” View full resource at news.yahoo.com
Most Recently Shared on March 28, 2012 at 1:38 pm By:
Allergan Announces Positive Top-Line Results from Phase III BOTOX® Overactive Bladder Program: Allergan, Inc. (N... http://t.co/L7vTRp48
Inspire Announces Results Of Second Phase 3 Trial With Denufosol For Cystic Fibrosis
medicalnewstoday.com — “Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced the top-line results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis (CF).” View full resource at medicalnewstoday.com
Most Recently Shared on January 5, 2011 at 2:05 pm By:
MNT Cystic Fibrosis Health News
Inspire Announces Results Of Second Phase 3 Trial With Denufosol For Cystic Fibrosis http://mnt.to/3PCq #cysticfibrosis
Advertisement
